Literature DB >> 27042226

Upregulation of microrna-451 increases the sensitivity of A549 cells to radiotherapy through enhancement of apoptosis.

Feng Tian1, Yong Han1, Xiaolong Yan1, Daixing Zhong1, Guang Yang1, Jie Lei1, Xiaofei Li1, Xiaoping Wang1.   

Abstract

BACKGROUND: As radioresistance of non-small cell lung cancers (NSCLC) is one of the main causes of failure in radiotherapy, we examined whether micro ribonucleic acid (miR-451) could function as a potential radiosensitizer of NSCLC and the related mechanism.
METHODS: Radioresistant NSCLC cell line A549 was transfected with pre-miR-451 or a scrambled control. The miR-451 messenger RNA level, colony-forming ability, apoptosis, and phosphatase and tensin homolog (PTEN) protein level of 549 cells were examined by real-time polymerase chain reaction, clonogenic assay, flow cytometry analysis, and Western blot.
RESULTS: Upregulation of miR-451 enhanced the suppressive effects of irradiation on the colony-forming ability of A549 cells. The apoptosis and PTEN expression of A549 cells post-irradiation were also enhanced by upregulation of miR-451.
CONCLUSIONS: Upregulation of miR-451 sensitized radioresistant NSCLC A549 cells to irradiation through the enhancement of apoptosis. The activation of PTEN post-irradiation was possibly correlated with the radiosensitization of A549 cells induced by miR-451 overexpression.

Entities:  

Keywords:  Apoptosis; PTEN; miR‐451; non‐small cell lung cancer; radiosensitization

Year:  2015        PMID: 27042226      PMCID: PMC4773304          DOI: 10.1111/1759-7714.12318

Source DB:  PubMed          Journal:  Thorac Cancer        ISSN: 1759-7706            Impact factor:   3.500


Introduction

As the leading cause of cancer death and the most commonly diagnosed cancer worldwide, lung cancer can be classified into two major groups: small cell lung cancer (SCLC) and non‐small cell lung cancer (NSCLC). NSCLC represents the majority of lung cancer cases and the survival rate at five years is generally less than 15%.1 Radiotherapy is one of the important approaches and plays a critical role in locally advanced NSCLC treatment.2 However, therapeutic outcomes of radiotherapy are often not fully satisfactory, and development of radioresistance is a significant problem which limits the treatment efficiency of radiotherapy for NSCLC.3 Therefore, identification of the radiosensitizer candidates of NSCLC is urgent in order to make clinical strategy developments for the treatment of NSCLC. Micro ribonucleic acids (miRNAs or miRs) are small endogenous non‐coding single‐stranded RNA molecules of about 18–25 nucleotides. MiRs play a key regulatory role in the expression of various oncogenes and tumor suppressor genes, which makes them one of the most relevant determinants of cancer biology.4, 5 In addition, more and more studies have reported that miRs are related to the radiotherapy response of various cancers, including NSCLC.6, 7, 8, 9 Among the miRs, miR‐451 was reported to possibly function as a tumor suppressor.10, 11 Moreover, miR‐451 was found to be downregulated in NSCLC and upregulated in radiotherapy sensitive NSCLC patients, compared with radiotherapy resistant counterparts.12, 13, 14 This indicates that the radioresistance of NSCLC might be related to the downregulation of miR‐451. Phosphatase and tensin homolog (PTEN) is a phosphatase that antagonizes the phosphatidylinositol‐4,5‐bisphosphate 3‐kinase (PI3K)/protein kinase B (AKT) signaling pathway by dephosphorylating phosphatidylinositol‐3,4,5‐triphosphate. PTEN acts as a tumor suppressor, and its activation may mediate the apoptosis of cancer cells.15, 16 During tumor development, mutations and deletions of PTEN occur that inactivate its enzymatic activity, leading to increased cell proliferation and reduced cell death. Frequent genetic inactivation of PTEN occurs in glioblastoma and endometrial and prostate cancers; reduced expression of PTEN is found in many tumor types, such as lung cancer. Because of a lack of PTEN function, the PI3K/AKT signal pathway is usually activated to enhance tumor cell survival.17 In addition, PTEN has been reported to play a critical role in radiotherapy and is related to regulation of the radiosensitivity of cancers by some miRs.18, 19 To date, it is unknown whether the upregulation of miR‐451 could sensitize NSCLC to radiotherapy and whether there is a correlation between miR‐451 and PTEN. To address these points, we used an A549 cell line to examine the radiosensitivity of NSCLC by overexpressing miR‐451 to detect the underlying mechanism.

Materials and methods

Cell culture

The NSCLC cell line A549 was cultured in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum, 100 U/mL penicillin, and 100 μg/mL streptomycin. Cell lines were cultured under an atmosphere of 5% CO2, with humidity at 37°C.

Cell transfection

Pre‐miR‐451 (50 pmol) and a scrambled control (50 pmol; Ambion, Austin, TX, USA) were transfected into NSCLC A549 cells grown in six‐well dishes (plated at 2 × 105 cells/well 24 hours before transfection). Transfection was performed with Lipofectamine 2000, according to the manufacturer's instructions (Invitrogen).

Micro ribonucleic acid (miR)‐451 detection by real‐time polymerase chain reaction

After transfection at different time points as indicated, cells were harvested and total RNA was extracted using TRIZOL reagent according to the manufacturer's protocol (Invitrogen). Polymerase chain reaction (PCR)‐based detection of mir‐451 level was performed by TaqMan miRNA assays (ABI, Forest City, CA, USA). Real‐time (RT)‐PCR results, recorded as threshold cycle numbers (Ct), were normalized against an internal control (U6 RNA), and then expressed as fold changes.20, 21

Irradiation treatment

Transfected cells (2 × 105 cells per well) were irradiated at room temperature with an RCR‐120 60Co γ‐ray therapeutic machine (Toshiba, Tokyo, Japan), at a dose rate of 1.6 Gy/min. Nonirradiated controls were handled identically to irradiated cells, with the exception of radiation treatment.

Assessment of clonogenicity

After exposure to various doses of irradiation (0, 2, 4 or 6 Gy), transfected cells were plated at low density (5 × 102 cells/10 cm plate) and incubated for 14 days at 37°C in a humidified atmosphere containing 5% CO2. Colony formation and growth were visualized with Giemsa staining. The number of colonies containing at least 50 cells was determined, and surviving fractions were calculated relative to the control nonirradiated cells.

Flow cytometry analysis of apoptosis

Forty‐eight hours after exposure (or sham exposure) to 6 Gy of irradiation, transfected cells were harvested following mild trypsinization, washed in phosphate‐buffered saline, and stained with fluorescein isothiocyanate‐labeled annexin V (Roche Applied Science, Basel, Switzerland) and propidium iodide. Apoptotic cells were measured using a fluorescence‐activated cell sorter apparatus (Becton Dickinson, Bellport, NY, USA).

Western blot analysis

After 6 Gy of irradiation, protein extraction from 1 × 106 transfected cells was performed with lysis buffer (20 mM Tris‐hydrochloride pH 7.4, 150 mM sodium chloride, 1% Triton X‐100, 0.1 mM ethylenediaminetetraacetic acid, 1 mM ethylene glycol tetraacetic acid, 2 mM sodium orthovanadate, 2 mM sodium fluoride, and Complete Protease Inhibitor Mix [Roche Applied Science, Mannheim, Germany]). Protein concentration was measured by BCA protein assay (Pierce, Thermo Scientific, Rockford, IL, USA) and samples were resolved on a 10% sodium dodecyl sulfatepolyacrylamide gel electrophoresis gel, followed by transfer to nitrocellulose membranes. Membranes were blocked in 5% non‐fat dry milk in Tris Buffer saline Tween‐20 at room temperature and probed with primary antibodies (anti‐PTEN antibody [Santa Cruz Biotechnology, Paso Robles, CA, USA] and anti‐ß‐actin antibody [Cell Signaling, Danvers, MA, USA]) overnight at 4°C and with secondary antibody for two hours at room temperature. Antibody complexes were visualized using an enhanced chemiluminescence‐Western blotting detection system (Thermo Scientific).

Statistical analysis

All experimental data were shown as the mean ± standard deviation. Differences between samples were analyzed using the Student's t‐test. Statistical significance was accepted at P < 0.05. Statistical analysis was performed using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA).

Results

MiR‐451 was upregulated in A549 cells by pre‐miR‐451 transfection

We performed RT‐PCR analysis of miR‐451 expression in NSCLC A549 cells transfected with pre‐miR‐451 or a scrambled control to validate transfection efficiency. As shown in Figure 1, the relative expression level of miR‐451 was significantly higher in pre‐miR‐451‐transfected A549 cells compared with those transfected with the scrambled control (P < 0.05). Even at 72 hours after transfection, there was still about 30‐fold induction. This data confirmed the overexpression of miR‐451 by transfecting pre‐miR‐451 into A549 cells.
Figure 1

Micro ribonucleic acid (miR)‐451 was successfully upregulated in A549 cells by pre‐miR‐451 transfection. Relative expression levels of miR‐451 in A549 cells were measured at 24, 48, and 72 hours after transient transfection with pre‐miR‐451 by real‐time quantitative polymerase chain reaction. RNU6 served as an endogenous control. Each value represents the mean ± standard deviation of three independent experiments. *P < 0.05 versus cells transfected with scrambled control.

Micro ribonucleic acid (miR)‐451 was successfully upregulated in A549 cells by pre‐miR‐451 transfection. Relative expression levels of miR‐451 in A549 cells were measured at 24, 48, and 72 hours after transient transfection with pre‐miR‐451 by real‐time quantitative polymerase chain reaction. RNU6 served as an endogenous control. Each value represents the mean ± standard deviation of three independent experiments. *P < 0.05 versus cells transfected with scrambled control.

Upregulation of miR‐451 sensitized A549 cells to irradiation

To examine whether miR‐451 upregulation could sensitize radioresistant NSCLC A549 cells to irradiation, clonogenic assay was performed 14 days after pre‐miR‐451‐transfected A549 cells and scrambled control‐transfected A549 cells were irradiated at a dose of 0, 2, 4 or 6 Gy. The survival fraction in pre‐miR‐451‐transfected A549 cells was suppressed compared with the scrambled control group following irradiation, implying that upregulation of miR‐451 could enhance the suppressive effects of irradiation on the colony‐forming ability of A549 cells and sensitize radioresistant NSCLC A549 cells to irradiation (Fig 2).
Figure 2

Survival fraction of A549 cells was suppressed following irradiation by micro ribonucleic acid (miR)‐451 overexpression. Clonogenicity was evaluated by Giemsa staining and presented as the percentage of colonies formed in A549 cells treated with irradiation and transfected with pre‐miR‐451 or scrambled control relative to untreated cells. Each value represents the mean ± standard deviation of three independent experiments. , scrambled; , pre‐miR‐451.

Survival fraction of A549 cells was suppressed following irradiation by micro ribonucleic acid (miR)‐451 overexpression. Clonogenicity was evaluated by Giemsa staining and presented as the percentage of colonies formed in A549 cells treated with irradiation and transfected with pre‐miR‐451 or scrambled control relative to untreated cells. Each value represents the mean ± standard deviation of three independent experiments. , scrambled; , pre‐miR‐451.

Irradiation‐induced apoptosis of A549 cells was enhanced by upregulation of miR‐451

Cell apoptosis was analyzed with flow cytometry after A549 cells transfected with pre‐miR‐451 or a scrambled control were exposed (or sham exposed) to 6 Gy of irradiation. As shown in Figure 3, cells overexpressing miR‐451 exhibited a higher level of apoptosis compared to scrambled control cells without irradiation. Moreover, when cells were exposed to 6 Gy of irradiation, although more apoptotic cells were found both in miR‐451‐overexpressing and scrambled control cells, the amount of apoptosis induced by irradiation in miR‐451‐overexpressing cells was significantly greater than in the scrambled control cells (P < 0.05). This suggested that upregulation of miR‐451 could promote radiosensitivity of NSCLC A549 cells by enhancing cell apoptosis.
Figure 3

Irradiation‐induced apoptosis of A549 cells was enhanced by by micro ribonucleic acid (miR)‐451 overexpression. The apoptotic A549 cells were stained with annexin V‐ fluorescein isothiocyanate and propidium iodide and examined by flow cytometry. The percentage of apoptotic cells is presented and each value represents the mean ± standard deviation of three independent experiments. *P < 0.05 versus 6 Gy irradiation group.

Irradiation‐induced apoptosis of A549 cells was enhanced by by micro ribonucleic acid (miR)‐451 overexpression. The apoptotic A549 cells were stained with annexin Vfluorescein isothiocyanate and propidium iodide and examined by flow cytometry. The percentage of apoptotic cells is presented and each value represents the mean ± standard deviation of three independent experiments. *P < 0.05 versus 6 Gy irradiation group.

Phosphatase and tensin homolog expression was promoted in miR‐451 upregulated A549 cells after irradiation

To detect the association between miR‐451 and PTEN, the protein level of PTEN in NSCLC A549 cells following overexpression of miR‐451 was detected by Western blot analysis. Without irradiation, PTEN protein was expressed at low levels in NSCLC A549 cells. After treatment with either pre‐miR‐451‐transfection or 6 Gy irradiation, the PTEN protein level in the A549 cells slightly increased. Moreover, the combination of miR‐451 overexpression and irradiation notably promoted PTEN expression compared to the corresponding control group (Fig 4). This result indicated that miR‐451 overexpression‐induced apoptosis enhancement after irradiation might be associated with the upregulation of the PTEN protein level in A549 cells.
Figure 4

Phosphatase and tensin homolog (PTEN) expression was promoted in micro ribonucleic acid (miR)‐451‐overexpressed A549 cells after irradiation (IR). The PTEN protein level in A549 cells with (or without) miR‐451 overexpression after exposure (or sham exposure) to irradiation was measured by Western blot. Results shown are representative of three independent experiments.

Phosphatase and tensin homolog (PTEN) expression was promoted in micro ribonucleic acid (miR)‐451‐overexpressed A549 cells after irradiation (IR). The PTEN protein level in A549 cells with (or without) miR‐451 overexpression after exposure (or sham exposure) to irradiation was measured by Western blot. Results shown are representative of three independent experiments.

Discussion

Conventionally, it is believed that radioresistance is a major obstacle in locally advanced NSCLC treatment. To overcome this problem, radiosensitizers have been pursued for a long time. In recent years, miRs have been regarded as potential candidates to regulate the radiosensitivity of NSCLC. Some were reported to induce radiosensitivity,14, 22, 23 while others were reported to confer radioresistance.6, 9, 24 To date, there is little information about the role of miR‐451 in NSCLC response to radiotherapy. Because clonogenic assay is frequently used in cancer research laboratories to determine the effectiveness of irradiation on the survival and proliferation of tumor cells, changes in the colony‐forming ability of radioresistant NSCLC A549 cells caused by miR‐451 overexpression after irradiation were examined in this study.25 As expected, by increasing the inhibition of the survival fraction of A549 cells caused by various doses of irradiation, we found that upregulation of miR‐451 sensitized A549 cells to irradiation. Previously, Bandres et al. found that overexpression of miR‐451 in gastric and colorectal cancer cells reduced cell proliferation and increased sensitivity to radiotherapy.26 However, almost no information is available regarding the effects of miR‐451 overexpression on the radiosensitivity of NSCLC. Wang et al. compared the expression profile of miRNA in radiotherapy sensitive and resistant groups of NSCLC patients and noted that the miR‐451 expression level in the radiotherapy sensitive NSCLC group was much higher than in the radiotherapy resistant group. However, they did not further explore the function of miR‐451 in radiotherapy for NSCLC.14 Our data showed that upregulation of miR‐451 could possibly enhance the sensitivity of NSCLC to radiotherapy and miR‐451 might be considered a potential radiosensitizer of NSCLC. Because cell apoptosis is one of the most critical reasons underlying tumor growth inhibition caused by irradiation, we examined whether miR‐451 overexpression could increase the apoptosis of NSCLC A549 cells induced by irradiation, which might account for the higher sensitivity to irradiation of A549 cells resulting from miR‐451 overexpression. It has been reported that overexpression of miR‐451 could induce NSCLC cell apoptosis.27, 28 Accordingly, our results were consistent with previous studies. Moreover, we further demonstrated that upregulation of miR‐451 enhanced irradiation‐induced apoptosis of A549 cells, suggesting that increased radiosensitivity of NSCLC A549 cells by miR‐451 overexpression might be attributed, at least in part, to the enhancement of cell apoptosis. This similar function of miR‐451 was also found by Zhang et al. in nasopharyngeal carcinoma cells by showing that the high levels of miR‐451 expression enhanced radiosensitivity by increasing apoptosis.29 Phosphatase and tensin homolog is one of the most important proteins associated with the regulation of cancer cell apoptosis, and the activation of PTEN plays a crucial role in the mediation of cell apoptosis induced by irradiation. Zhuang et al. reported that the irradiation‐induced apoptosis of lung cancer cells was increased by the upregulation of PTEN.30 In addition, Qu et al. noted that knocking down miR‐205 in nasopharyngeal carcinoma cells compromises the inhibition of PTEN and increases cell apoptosis post‐irradiation.31 It is unclear whether upregulation of miR‐451 could affect PTEN expression; therefore our study detected PTEN protein levels in NSCLC A549 cells. Our results showed that PTEN expression after irradiation was remarkably increased in miR‐451 overexpressed A549 cells, indicating that there might be an association between upregulation of PTEN protein level and apoptosis enhancement post‐irradiation, induced by miR‐451 overexpression in A549 cells.

Conclusion

In conclusion, the present study demonstrated that miR‐451 was a regulator of NCSLC radiosensitivity. Upregulation of miR‐451 sensitized radioresistant NSCLC A549 cells to irradiation through the enhancement of apoptosis. The activation of PTEN post‐irradiation might be correlated with the radiosensitization of A549 cells induced by miR‐451 overexpression. Our results will assist in overcoming NSCLC radioresistance and developing new therapeutic strategies for NSCLC. Further studies on the targets of miR‐451 in radiosensitization and the mechanism underlying PTEN activation after irradiation, accompanied by the upregulation of miR‐451 in NSCLC, are still needed.

Disclosure

No authors report any conflict of interest.
  31 in total

1.  Effect of miR-34b overexpression on the radiosensitivity of non-small cell lung cancer cell lines.

Authors:  Joana Balça-Silva; Sílvia Sousa Neves; Ana Cristina Gonçalves; Ana Margarida Abrantes; João Casalta-Lopes; Maria Filomena Botelho; Ana Bela Sarmento-Ribeiro; Henriqueta Coimbra Silva
Journal:  Anticancer Res       Date:  2012-05       Impact factor: 2.480

2.  Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation.

Authors:  Pierluigi Gasparini; Francesca Lovat; Matteo Fassan; Lucia Casadei; Luciano Cascione; Naduparambil K Jacob; Stefania Carasi; Dario Palmieri; Stefan Costinean; Charles L Shapiro; Kay Huebner; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-10       Impact factor: 11.205

3.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.

Authors:  P A Steck; M A Pershouse; S A Jasser; W K Yung; H Lin; A H Ligon; L A Langford; M L Baumgard; T Hattier; T Davis; C Frye; R Hu; B Swedlund; D H Teng; S V Tavtigian
Journal:  Nat Genet       Date:  1997-04       Impact factor: 38.330

4.  Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells.

Authors:  Hua Zhu; Hao Wu; Xiuping Liu; Brad R Evans; Daniel J Medina; Chang-Gong Liu; Jin-Ming Yang
Journal:  Biochem Pharmacol       Date:  2008-06-24       Impact factor: 5.858

5.  Clinical evaluation of microRNA expression profiling in non small cell lung cancer.

Authors:  A Markou; I Sourvinou; P A Vorkas; G M Yousef; E Lianidou
Journal:  Lung Cancer       Date:  2013-06-10       Impact factor: 5.705

6.  MicroRNA-17-92 significantly enhances radioresistance in human mantle cell lymphoma cells.

Authors:  Ping Jiang; En Y Rao; Na Meng; Yong Zhao; Jun J Wang
Journal:  Radiat Oncol       Date:  2010-11-01       Impact factor: 3.481

7.  Upregulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549).

Authors:  Hai-Bo Bian; Xuan Pan; Jin-Song Yang; Zhao-Xia Wang; Wei De
Journal:  J Exp Clin Cancer Res       Date:  2011-02-17

8.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

9.  MiR-451 increases radiosensitivity of nasopharyngeal carcinoma cells by targeting ras-related protein 14 (RAB14).

Authors:  Tian Zhang; Quanquan Sun; Tongxin Liu; Jiarong Chen; Shasha Du; Chen Ren; Guixiang Liao; Yawei Yuan
Journal:  Tumour Biol       Date:  2014-09-09

10.  miRNA-214 modulates radiotherapy response of non-small cell lung cancer cells through regulation of p38MAPK, apoptosis and senescence.

Authors:  H Salim; N S Akbar; D Zong; A H Vaculova; R Lewensohn; A Moshfegh; K Viktorsson; B Zhivotovsky
Journal:  Br J Cancer       Date:  2012-08-28       Impact factor: 7.640

View more
  10 in total

Review 1.  miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives.

Authors:  Mateusz Florczuk; Adam Szpechcinski; Joanna Chorostowska-Wynimko
Journal:  Target Oncol       Date:  2017-04       Impact factor: 4.493

2.  LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.

Authors:  Linmei Wang; Xueqin Shang; Qingqing Feng
Journal:  Cancer Biol Ther       Date:  2018-11-27       Impact factor: 4.742

Review 3.  Molecular mechanisms underlying stress response and adaptation.

Authors:  Shuang Sun; Jun Zhou
Journal:  Thorac Cancer       Date:  2017-12-26       Impact factor: 3.500

4.  The low expression of miR-451 predicts a worse prognosis in non-small cell lung cancer cases.

Authors:  Akiteru Goto; Masamitsu Tanaka; Makoto Yoshida; Michinobu Umakoshi; Hiroshi Nanjo; Kouya Shiraishi; Motonobu Saito; Takashi Kohno; Sei Kuriyama; Hayato Konno; Kazuhiro Imai; Hajime Saito; Yoshihiro Minamiya; Daichi Maeda
Journal:  PLoS One       Date:  2017-07-12       Impact factor: 3.240

Review 5.  Regulation of PTEN expression by noncoding RNAs.

Authors:  Wang Li; Ting Zhang; Lianying Guo; Lin Huang
Journal:  J Exp Clin Cancer Res       Date:  2018-09-10

Review 6.  Tissue-specific and exosomal miRNAs in lung cancer radiotherapy: from regulatory mechanisms to clinical implications.

Authors:  Long Long; Xue Zhang; Jian Bai; Yizhou Li; Xiaolong Wang; Yunfeng Zhou
Journal:  Cancer Manag Res       Date:  2019-05-13       Impact factor: 3.989

7.  microRNA-451a regulates colorectal cancer proliferation in response to radiation.

Authors:  Rebecca Ruhl; Shushan Rana; Katherine Kelley; Cristina Espinosa-Diez; Clayton Hudson; Christian Lanciault; Charles R Thomas; V Liana Tsikitis; Sudarshan Anand
Journal:  BMC Cancer       Date:  2018-05-03       Impact factor: 4.430

8.  Delta-tocotrienol inhibits non-small-cell lung cancer cell invasion via the inhibition of NF-κB, uPA activator, and MMP-9.

Authors:  Lichchavi D Rajasinghe; Rohini H Pindiprolu; Smiti Vaid Gupta
Journal:  Onco Targets Ther       Date:  2018-07-24       Impact factor: 4.147

9.  Radiation Exposure of Peripheral Mononuclear Blood Cells Alters the Composition and Function of Secreted Extracellular Vesicles.

Authors:  Simone Moertl; Dominik Buschmann; Omid Azimzadeh; Michael Schneider; Rosemarie Kell; Klaudia Winkler; Soile Tapio; Sabine Hornhardt; Juliane Merl-Pham; Michael W Pfaffl; Michael J Atkinson
Journal:  Int J Mol Sci       Date:  2020-03-27       Impact factor: 5.923

Review 10.  miR-451: A Novel Biomarker and Potential Therapeutic Target for Cancer.

Authors:  Hua Bai; Suhui Wu
Journal:  Onco Targets Ther       Date:  2019-12-16       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.